13048-99-2

Usage

Uses

Used in Pharmaceutical Industry:
GLYCINE N-BUTYL ESTER HYDROCHLORIDE is used as a chemical intermediate for the synthesis of various drugs. Its role in drug production is crucial due to its ability to facilitate the formation of new pharmaceutical compounds, contributing to the development of novel treatments and medications.
Used in Agrochemical Industry:
GLYCINE N-BUTYL ESTER HYDROCHLORIDE is used as a building block in the production of pesticides. Its involvement in the synthesis of agrochemicals helps in creating effective solutions for pest control, thereby supporting agricultural productivity and crop protection.
Used in Chemical Synthesis:
GLYCINE N-BUTYL ESTER HYDROCHLORIDE is used as a versatile compound in chemical synthesis processes. Its utility in facilitating reactions and syntheses makes it an important component in the creation of a wide range of products across different industries.

InChI:InChI=1/C6H13NO2.ClH/c1-2-3-4-9-6(8)5-7;/h2-5,7H2,1H3;1H

Upstream product

• 6000-43-7 2-aminoethanoic acid hydrochloride 
• 71-36-3 butan-1-ol 

Downstream Products

• 24761-88-4 1-butyl diazoacetate 
• 58511-01-6 Isothiocyanato-acetic acid butyl ester 
• 17046-22-9 butyl-2-isocyanatoacetate 

Relevant academic research and scientific papers

HIV INTEGRASE INHIBITORS

Stereoisomers of compounds of Formula I are disclosed: wherein V1,V2, R5a, R5b, R5c, R8 and R9b are defined herein and wherein the stereoisomer contains 2 chiral centers in the 8-membered ring and one of the chiral centers is due to the presence of a chiral ring carbon. The isomers are inhibitors of HIV integrase and inhibitors of HIV replication, and are useful for the prophylaxis or treatment of infection by HIV and the prophylaxis, treatment, or delay in the onset or progression of AIDS. The compounds are employed against HIV infection and AIDS as compounds per se or in the form of pharmaceutically acceptable salts. The compounds and their salts can be employed as ingredients in pharmaceutical compositions, optionally in combination with other antivirals, immunomodulators, antibiotics or vaccines.

Crystalline forms of an HIV integrase inhibitor

Crystalline forms of a hexahydro-diazocinonaphthyridine trione compound are disclosed. The compound and its crystalline forms thereof are HIV integrase inhibitors useful for the prophylaxis or treatment of HIV infection or for the prophylaxis, treatment or delay in the onset or progression of AIDS.

HIV INTEGRASE INHIBITORS

Tricyclic compounds of Formula (I) are inhibitors of HIV integrase and inhibitors of HIV replication: wherein bond a, ring A, Rl, R2 and R3 are defined herein. The compounds are useful for the prophylaxis or treatment of infection by HIV and the prophylaxis, treatment, or delay in the onset of AIDS. The compounds are employed against HIV infection and AIDS as compounds per se or in the form of pharmaceutically acceptable salts. The compounds and their salts can be employed as ingredients in pharmaceutical compositions, optionally in combination with other antivirals, immunomodulators, antibiotics or vaccines.

HIV INTEGRASE INHIBITORS

Hydroxy (tetra- or hexa-)hydronaphthyridine dione compounds of Formula (I) are inhibitors of HIV integrase and inhibitors of HIV replication wherein X1, X2, R4 and R5 are defined herein. The compounds are useful in the prevention and treatment of infection by HIV and in the prevention, delay in the onset, and treatment of AIDS. The compounds are employed against HIV infection and AIDS as compounds per se or in the form of pharmaceutically acceptable salts. The compounds and their salts can be employed as ingredients in pharmaceutical compositions, optionally in combination with other antivirals, immunomodulators, antibiotics or vaccines.